CMCaleb Mpyet

Caleb Mpyet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caleb Mpyet has a total of 268 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of complementary indicators in trachoma surveys in Nigeria: results of impact surveys in two local government areas

    by Caleb Mpyet, Sunday Isiyaku, Joy Shu’AIbu, Teyil Wamyil-Mshelia, Grace Ajege, Suzie Madaki, Fatai Oyediran, Laura Senyonjo, Cristina Jimenez, E Michelle Taylor, et al.

    Objectives: Trachoma elimination progress is hampered in some districts by persistent or recrudescent trachomatous inflammation—follicular (TF). In Sokoto State, Nigeria, two local government areas (LGAs) have been classified as having persistent TF. We aimed to determine whether there was ongoing, programmatically significant conjunctival Chlamydia trachomatis (Ct) community transmission in these LGAs. Methods: In addition to examination for trachoma clinical signs, we took conjunctival swabs (for Ct nucleic acid amplification testing) from children aged 1–5 years, and dried blood spots [for estimation of anti-chlamydial plasmid gene protein 3 seroconversion rates (SCRs)] from children aged 1–9 years. Results: In Binji LGA, TF prevalence (4.1%) was below the elimination threshold, SCR was 1.1 per 100 child years in 1–5-year-olds, and Ct infection prevalence was 0.1%. In Silame LGA, TF prevalence (5.6%) was above the elimination threshold, but SCR was 1.6, and Ct infection prevalence was 0.2%. Conclusion: Binji has attained the active trachoma elimination threshold, thus transitioning to surveillance. In Silame, despite the TF prevalence remaining slightly above threshold, the low Ct infection prevalence and low SCR suggest Ct transmission is minimal, and mass drug administration will not be conducted. Silame can therefore also transition to the surveillance phase. Complementary trachoma survey indicators help ensure appropriate and cost-efficient programmatic decisions.

  • Open Access

    Trichiasis with and without tarsal conjunctival scarring: A multi-country observational study

    by Esmael Habtamu, Caleb Mpyet, Francis Mugume, Gladys Atto, Fikre Seife, Gilbert Baayenda, Sharone Backers, Ana Bakhtiari, Zerihun Tadesse, Scott D. Nash, et al.

    There has been discussion regarding the definition of the clinical sign trachomatous trichiasis (TT) for the purposes of determining elimination of trachoma as a public health problem, and whether the definition should include the presence of trachomatous scarring (TS). A multi-country observational study was conducted in Ethiopia, Uganda and Nigeria to assess whether TS grading by field graders using the WHO simplified system in trachoma surveys are comparable with expert grading of tarsal conjunctival scarring (TCS) using a detailed system. The primary outcome was the proportion of eyes graded as “No TS” in the surveys but with TCS from expert photographic grading (the negative predictive value, NPV). In Ethiopia, Uganda and Nigeria, 545 (438 trichiasis cases and 107 comparisons), 256 (156 trichiasis cases and 100 comparisons), and 468 (352 trichiasis cases and 116 comparisons) participants, respectively, were enrolled. In Ethiopia, among 111 trichiatic eyes graded “No TS” in the surveys, 103 (92.8%) had TCS in expert photo grading, NPV 7.2% (95% CI 3.2%–13.7%). In Uganda, among 28 trichiatic eyes graded “No TS” in the surveys, 19 (67.9%) had TCS in expert photo grading, NPV 32.1% (95% CI 15.9%–52.4%). In Nigeria, among 111 trichiatic eyes graded “No TS” in the surveys, 100 (90.1%) had TCS in expert photo grading, NPV 9.9% (95% CI 5.0%–17.0%). Across settings, among eyes misdiagnosed as “No TS” in the survey, 174/250 (69.6%) had extensive TCS (patches of scarring occupying ≥1/3 of the upper tarsal conjunctiva). Trichiatic eyes with TCS had more severe entropion, trichiasis, conjunctival inflammation, and corneal opacity than those without TCS. In all three settings, including TS to define a trichiasis “trachomatous” in a survey could result in the underestimation of the burden of TT. However, TCS can be effectively used to determine TT severity and management.


  • Open Access

    Does persistent active trachoma mandate antibiotic mass drug administration? A comparison of prevalence of trachomatous inflammation–follicular with that of conjunctival infection and anti-chlamydial antibodies, Western Province, Zambia

    by Consity Mwale, Chileshe Mboni, Ngonda Saasa, Chummy S Sikasunge, Chisanga Chelu, Phyllis M Moonga, Grace Hameja, Levison Nkhoma, Frank Shamilimo, Namasiku S Kunda, et al.

    Background: The evaluation unit comprising Kaoma, Luampa, and Nkeyema districts, Western Province, Zambia, has persistent active trachoma. In 2023, we sought to compare the evaluation unit–level prevalence of the active trachoma sign, trachomatous inflammation–follicular (TF), to that of conjunctival Chlamydia trachomatis (Ct) infection and anti-Chlamydia trachomatis (Ct) seropositivity. Methods: We conducted a cluster-sampled cross-sectional survey. In selected households, we examined all consenting residents ≥1 y of age for trachoma. We collected dried blood spots (DBSs) by finger-prick from children ages 1–9-y and conjunctival swabs from the left eyes of children ages 1–5-y. DBSs were tested for antibodies to the C. trachomatis antigen Pgp3 by lateral flow assay. We tested conjunctival swabs for C. trachomatis DNA by GeneXpert polymerase chain reaction (PCR). Results: The TF prevalence in children ages 1–9-y was 9.2%. In children ages 1–5-y, anti-Pgp3 seroprevalence was 1.7% and the seroconversion rate was 0.6 per 100 person-years. The prevalence of conjunctival C. trachomatis DNA in children ages 1–5-y was 0%. Conclusions: Based on TF prevalence, this population qualified for additional antibiotic mass drug administration rounds, but PCR and serology—more specific indicators of current or recent C. trachomatis infection than TF—confirmed an absence of significant current community C. trachomatis transmission, allowing a transition to surveillance. Adding these indicators is helpful in persistent active trachoma.

  • Open Access

    Testing for Antibodies to Four Parasites in Residual Blood Specimens from Trachoma Surveys in Kiribati, 2015–2019

    by AdeSubomi O. Adeyemo, Raebwebwe Taoaba, Diana Martin, E. Brook Goodhew, Robert Butcher, Caleb Mpyet, Emma Harding-Esch, Anasaini Cama, Sarah Anne J. Guagliardo, Sarah Gwyn, et al.

    : To assess the prevalence of several parasitic infections in Kiribati, dried blood spots collected during trachoma prevalence surveys in the two major population centers in 2015, 2016, and 2019 were tested using multiplex bead-based serologic assays to detect IgG antibodies against four pathogens of public health interest: Toxoplasma gondii (T. gondii), Taenia solium (T. solium), Strongyloides stercoralis (S. stercoralis), and Toxocara canis (T. canis). In Kiritimati Island, the seroprevalences of T. solium recombinant antigen for detection of cysticercosis antibodies (T24H) and recombinant antigen for detection of taeniasis antibodies (ES33) were ≤4% in both surveys, whereas in Tarawa, the T24H seroprevalence was 2% (2016) and 7% (2019) and the ES33 seroprevalence was ≤3% in both surveys. At both sites, the seropositivity of S. stercoralis recombinant antigen for detection of Strongyloides was 0–4%, and for T. canis, the C-type lectin-1 antigen was 0–1% in all surveys. For T. gondii, the surface antigen glycoprotein 2A antigen seroprevalences on Kiritimati Island were 41% (2015) and 36% (2019), and in Tarawa, they were 36% (2016) and 22% (2019), suggesting that T. gondii infections are common in Kiribati, whereas the other pathogens are not.

  • Open Access

    Trichiasis With and Without Tarsal Conjunctival Scarring: a multi-country observational study

    by Esmael Habtamu, Caleb Mpyet, Francis Mugume, Gladys Atto, Fikre Seife, Gilbert Baayenda, Sharone Backers, Ana Bakhtiari, Zerihun Tadesse, Scott D. Nash, et al.

    There has been discussion regarding the definition of the clinical sign trachomatous trichiasis (TT) for the purposes of determining elimination of trachoma as a public health problem, and whether the definition should include the presence of trachomatous scarring (TS). A multi-country observational study was conducted in settings with varying TT burdens in Ethiopia, Uganda and Nigeria to determine if the TS grading collected from trichiasis cases by field graders in trachoma surveys using a simplified grading scheme are comparable with tarsal conjunctival scarring (TCS) grading by experts using a detailed grading scheme. The primary outcome was the proportion of eyes that were originally graded in the surveys as “No TS” but had some degree of TCS from expert photographic grading (the negative predictive value, NPV). In Ethiopia, Uganda and Nigeria, 545 (438 cases and 107 comparisons), 256 (156 trichiasis cases and 100 comparisons), and 468 (352 trichiasis cases and 116 comparisons) participants, respectively, were enrolled. In Ethiopia, among 111 trichiatic eyes graded “No TS” in the surveys, 103 (92.8%) had TCS in expert photo grading, NPV 7.2% (95% CI 3.2%– 13.7%). In Uganda, among 28 trichiatic eyes graded “No TS” in the surveys, 19 (67.9%) had TCS in expert photo grading, NPV 32.1% (95% CI 15.9%–52.4%). In Nigeria, among 111 trichiatic eyes graded “No TS” in the surveys, 100 (90.1%) had TCS in expert photo grading, NPV 9.9% (95% CI 5.0%–17.0%). Among eyes misdiagnosed as “No TS” in the survey grading in all the three settings, 174/250 (69.6%) were those with extensive TCS (patches of scarring occupying ≥1/3 of the upper tarsal conjunctiva). Trichiatic eyes with TCS had more severe entropion, trichiasis, conjunctival inflammation, and corneal opacity than those without TCS. In all three settings, including TS to define a trichiasis “trachomatous” in a survey could result in the underestimation of the burden of TT. However, TCS can be effectively used to determine TT severity and management.

  • Open Access

    Optimizing Trichiasis Case Finding to Attain the Elimination of Trachoma as a Public Health Problem

    by Joy Shu’aibu, Grace Ajege, Caleb Mpyet, Michael Dejene, Sunday Isiyaku, Abubakar Tafida, Michaela Kelly, Innocent Emereuwa, Paul Courtright

    Background: As national trachoma programmes increase efforts to reduce the burden of trachomatous trichiasis (TT), TT case finding and referral are critical public health programme components. Our research aimed to explore the most effective and efficient approaches to finding, referring, and managing TT cases. Methods: This was a prospective descriptive study, utilizing both routine programme data and primary data collection. This study compared four different approaches to finding TT cases across three different local government areas (LGAs) in Kano State, Nigeria. Each of the study LGAs was divided into four sub-units to accommodate the four different approaches. Results: The number of outreach attendees was 4795 across the four case finding approaches, and this varied hugely, with the smallest number and proportion (403, 0.26%) in settings only employing house-to-house case finding and the largest number and proportion (1901, 0.99%) when town criers were used. That said, the proportion of TT cases among people presenting at outreach was highest (32.5%) when house-to-house case finding was used and lowest (10.3%) when town criers were used. More female TT patients were found (53–70%) and had surgery (79–85%) compared to male cases, across all approaches. The average project expenditure for finding one TT case was similar for approaches that included house-to-house case finding (USD 5.4–6.3), while it was 3.5 times higher (USD 21.5 per TT case found) when town criers were used. Discussion: This study found that the house-to-house TT case finding approaches were the most efficient method with the highest yield of TT cases. Including other eye condition and/or vision testing yielded similar results but required more personnel and cost.


  • Open Access

    Tropical Data: supporting health ministries worldwide to conduct high-quality trachoma surveys

    by E M Harding-Esch, A Bakhtiari, S Boyd, C Burgert-Brucker, R Butcher, M Dejene, A Harte, P J Hooper, C Jimenez, E M Taylor, et al.

    Monitoring and evaluation are key to tracking progress towards achieving the 2030 targets for neglected tropical diseases (NTDs).1 Baseline data provide a reference point against which subsequent progress towards targets can be measured. For trachoma, the leading infectious cause of blindness worldwide, the Global Trachoma Mapping Project (GTMP) was the largest series of infectious disease surveys ever conducted. Baseline surveys were completed in 905 evaluation units (EUs; which for trachoma elimination purposes are defined as the normal administrative units for healthcare management, generally with populations of 100 000–250 000 people)2 across 29 countries, examining >2.6 million people.3 The results enabled trachoma interventions to be targeted and prioritised, with active trachoma (measured through the clinical sign trachomatous inflammation—follicular [TF]) confirmed to be a public health problem in 341 (38%) EUs and the late-stage, blinding, trachomatous trichiasis (TT) a public health problem in 473 (52%) EUs,3 with the highest burdens in Ethiopia and Nigeria.


  • Open Access

    Progress towards the elimination of trachoma in Nigeria

    by Caleb D Mpyet, Nicholas Olobio, Sunday Isiyaku, Teyil Wamyil-Mshelia, Grace Ajege, Christopher Ogoshi, Francisca Olamiju, Ijeoma Achu, Mohammed Dantani Adamu, Nasiru Muhammad, et al.

    Trachoma is targeted for elimination as a public health problem worldwide by 2030. In Nigeria, elimination activities are implemented at the local government area (LGA) level. They started in 2002 by conducting baseline population-based prevalence surveys (PBPSs), which continued in a systematic manner with engagement from the Global Trachoma Mapping Project in 2013, and subsequently Tropical Data. The results led to the development of Nigeria's first trachoma action plan and its subsequent revision with additional information. Following 449 baseline PBPSs, 122 LGAs had an active trachoma prevalence above the elimination threshold, requiring interventions, while 231 LGAs required community-based interventions for trichiasis management. By 2021, >34 million antibiotic treatments had been provided in 104 LGAs, with 89 LGAs eliminating active trachoma. Nationally, water and sanitation coverages increased by 3% and 18%, respectively, in 7 y. Systematic trichiasis case finding and management were carried out in 231 LGAs, resulting in the management of 102 527 people. Fifty-four LGAs decreased trichiasis prevalence unknown to the health system to <0.2% in persons ≥15 y of age. Where this elimination prevalence threshold was reached, trichiasis services were transitioned to routine eye/healthcare systems. Such progress relied on strong leadership and coordination from the national trachoma program and tremendous support provided by partners. Attaining elimination of trachoma as a public health problem in Nigeria by 2030 is feasible if funding support is sustained.


  • Open Access

    Addressing the challenges of reaching trachoma elimination: leveraging on lessons learnt from programme implementation

    by Caleb Mpyet, Kareen Ateken, Michael Dejene, Michaela Kelly, Grace Mwangi, Elena Schmidt

    Implementation of the Surgery, Antibiotic treatment, Face washing, Environmental improvement (SAFE)1 strategy recommended by the WHO has enabled 18 countries to attain the elimination of trachoma as a public health problem, and many more countries have made substantial progress on this journey. Implementing the SAFE strategy depends on the availability of data on the prevalence of trachomatous inflammation follicular in children aged 1–9 years and trachomatous trichiasis in people aged ≥15 years. It also requires systematic monitoring of mass drug administration coverage, surgery uptake and a range of behaviour change indicators. Challenges arising during programme implementation need to be promptly identified and addressed through operational research synergistically integrated in the programme cycle.

  • Open Access

    Prevalence of Trachoma following Implementation of the SAFE Strategy in Three Local Government Areas of Taraba State, North Eastern Nigeria

    by Francisca Olamiju, Sunday Isiyaku, Nicholas Olobio, Hammed Mogaji, Ijeoma Achu, Nasiru Muhammad, Sarah Boyd, Ana Bakhtiari, Apake Ebenezer, Cristina Jimenez, et al.

    In 2019–2020, one round of antibiotic mass drug administration (MDA) was implemented for trachoma elimination purposes in Donga, Gashaka, and Ussa local government areas (LGAs) of Taraba State, Nigeria, following baseline surveys in 2009 (Donga and Gashaka) and 2013–2014 (Ussa). Here, trachoma prevalence post-MDA in these three LGAs is reported. In 2019 (Gashaka and Ussa) and 2020 (Donga), population-based, cross-sectional surveys were conducted following World Health Organization (WHO) guidance. A two-stage cluster sampling strategy was used. All residents of selected households aged ≥1 year were examined by Tropical Data-certified graders for trachomatous inflammation—follicular (TF) and trachomatous trichiasis (TT) using the WHO simplified trachoma grading scheme. Data on water, sanitation, and hygiene (WASH) access were also collected. A total of 1,883 households participated. From these households, 4,885 children aged 1–9 years were enumerated, and 4,866 (99.6%) examined. There were 5,050 eligible adults (aged ≥15 years) enumerated in the same households, of whom 4,888 (96.8%) were examined. Age-adjusted TF prevalence in children aged 1–9 years was 0.22% (95% CI: 0.00–0.65) in Donga, 0.0% in Gashaka, and 0.19% (95% CI: 0.00–0.44) in Ussa. The age- and gender-adjusted TT prevalence unknown to the health system in adults aged ≥15 years was 0.08% (95% CI: 0.00–0.19) in Donga, 0.02% (95% CI: 0.00–0.06) in Gashaka, and 0.10% (95% CI: 0.01–0.18) in Ussa. In Donga, Gashaka, and Ussa, respectively, 66%, 49% and 63% of households had access to an improved drinking water source, and 68%, 56% and 29% had access to an improved latrine. In all LGAs, the elimination thresholds for TF and TT unknown to the health system have been attained in the target age groups. These LGAs should be re-surveyed after 2 years to show that reductions in TF prevalence have been sustained in the absence of MDA. Health authorities should continue to improve WASH facilities to reduce the risk of later recrudescence.